Multi-Center Clinical Study Intensifies First Strike at High-Risk Cancer in Kids

An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma - a deadly, hard-to-cure childhood cancer.

Read more: http://www.marketwatch.com/story/multi-center-clinical-study-intensifies-first-strike-at-high-risk-cancer-in-kids-2012-06-12